AU2002355653A1 - Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv - Google Patents

Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv

Info

Publication number
AU2002355653A1
AU2002355653A1 AU2002355653A AU2002355653A AU2002355653A1 AU 2002355653 A1 AU2002355653 A1 AU 2002355653A1 AU 2002355653 A AU2002355653 A AU 2002355653A AU 2002355653 A AU2002355653 A AU 2002355653A AU 2002355653 A1 AU2002355653 A1 AU 2002355653A1
Authority
AU
Australia
Prior art keywords
nef
tat
vaccine
against hiv
immunisation against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002355653A
Inventor
Peter Franz Ertl
John Philip Tite
Catherine Ann Van Wely
Gerald Voss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Glaxo Group Ltd
Original Assignee
GlaxoSmithKline Biologicals SA
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, Glaxo Group Ltd filed Critical GlaxoSmithKline Biologicals SA
Publication of AU2002355653A1 publication Critical patent/AU2002355653A1/en
Abandoned legal-status Critical Current

Links

AU2002355653A 2001-07-27 2002-07-26 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv Abandoned AU2002355653A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0118367.2 2001-07-27

Publications (1)

Publication Number Publication Date
AU2002355653A1 true AU2002355653A1 (en) 2003-02-17

Family

ID=

Similar Documents

Publication Publication Date Title
WO2001054719A3 (en) Vaccine for the prophylactic or therapeutic immunization against hiv
AU2002336760A1 (en) Mutable vaccines
AU2002236159A1 (en) Immunogenic complex
AU8499901A (en) Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
WO2003039470A3 (en) Polyvalent immunogen of hiv
IL150961A0 (en) Human immunodeficiency virus vaccine
AU1285300A (en) Hiv vaccine
AU2002221519A1 (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
AU2002361559A1 (en) Anticancer vaccine and diganostic methods and reagents
AU2003282498A1 (en) Hiv vaccine formulations
HUP0200841A2 (en) Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein
AU2002365275A1 (en) Novel chimeric rev, tat, and nef antigens
WO2005097179A3 (en) Stabilised tat antigen and the use thereof for anti-hiv vaccination
AU2002213882A1 (en) Attenuated hiv strains and use thereof
AU4472801A (en) Inactivated japanese B encephalitis vaccine and process for producing the same
AU2002365576A1 (en) Hiv envelope v3-ccr5 binding site immunogen
AU2001254561A1 (en) Immunizing against hiv infection
AU1032701A (en) Deglycosylated env/cd4 complex and the use thereof for vaccination against hiv
AU2002355653A1 (en) Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
AU2002343146A1 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
EP1490396A4 (en) Immunogenic hiv peptides for use as reagents and vaccines
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AP2388A (en) A group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof.
AU4957800A (en) Vaccine against isa virus
AU2002314274A1 (en) Vaccination against the feline immunodeficiency virus